Sideway near support line
WR crossed -80
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for pharmaceutical...
The next one the next one is some of you pro bably remembered DRRX , these stocks for folks who are serious and want to trade price action and the truth is that as traitors we really couldn't careless we don't give a hoot about what happens to a dog after we take our price friend after me repeat after me who cares if it's be down afterwards am I right just fell...
DURECT Corp. is a biopharmaceutical company, which engages in the research, development, and manufacturing of pharmaceutical products. The company products include alzet and lactel. Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to...
By looking at the indicators I use DRRX looks ready to go up. I've placed my order to be filled on Nov 12th. Let's see how this one goes. Purple line signifies my purchase date. All other indicators are positive for upward trend. Looks strong to me.
After breaking to higher ground a week ago on enormous volume, shares of DURECT CORP - NASDAQ:DRRX finds themselves consolidating the recent thrust in a Flag pattern on lower volume as we can observe from the Daily chart above.
In addition, DRRX is now trading above all of its important moving averages 20/50/200 DMA's, which from a technical perspective, is...
DRRX bouncing off its longterm support after a huge decline. Now it seems forming nice fallen angel formation with a higher low double bottom. We think it has good upside potential from here.
* Trade Criteria *
Date First Found- November 21, 2017
Pattern/Why- Fallen angel, Double bottom
Entry Target Criteria- Break of $1.12
Exit Target Criteria- 1st...
LONG After market crashed due to negative news. Price is back to 0.78 from nearly 2.00. More downside is always a possibility, but this drop went directly to prior support area. Expecting support to hold, and for price to continue long for a correction in the market.